Financials
- Market Capitalization 20.48 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.42
ratio cours/chiffre d'affaires
207.27
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4530 | LGVN Longeveron Inc. - Class A Common stock | 6.75 USD | -2.17% | +878.26% | +850.70% | +1081.52% | 21.52 M USD | ||
| 4539 | LEXX Lexaria Bioscience Corp. - Common Stock | 12.48 USD | +11.93% | +6.67% | +111.53% | +1302.25% | 20.62 M USD | ||
| 4544 | PTN Palatin Technologies, Inc. Common Stock | 11.51 USD | +15.22% | +8.38% | +45.15% | +58.76% | 20.48 M USD | ||
| 4545 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.63 USD | -8.28% | -8.41% | -1.33% | +115.90% | 20.45 M USD |